Preparation, characterization and evaluation of Marsupsin-phospholipid complex

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 129-137

  Sikarwar, Mukesh S ^a   Sharma, Shalini ^b   Jain, Amit K ^a   Parial, S D ^a  

^a B R NAHATA COLLEGE OF PHARMACY   (India)

^b D G M Ayurvedic Medical College   (India)

Author keywords

Characterization; Kinosome; Marsupsin; Pharmacokinetics

Indexed keywords

FLAVONOID; MARSUPIN; PHOSPHOLIPID; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; BENZOFURAN DERIVATIVE; CRESOL; DRUG CARRIER; MARSUPSIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG ISOLATION; DRUG RELEASE; DRUG RESPONSE; DRUG SOLUBILITY; DRUG STRUCTURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; PROTON NUCLEAR MAGNETIC RESONANCE; PTEROCARPUS; RABBIT; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD; CHEMISTRY; DIFFUSION; DRUG SCREENING; EVALUATION; MATERIALS TESTING; METHODOLOGY; TREATMENT OUTCOME;

ANIMALS; BENZOFURANS; CRESOLS; DIABETES MELLITUS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; HYPOGLYCEMIC AGENTS; MATERIALS TESTING; PHOSPHOLIPIDS; RABBITS; RATS; TREATMENT OUTCOME;

EID: 44849116340     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-007-9020-x     Document Type: Article

References (28)

1. B. Tripathi. Charak Samhita 2. Varanasi, India, Chaukhamba Surbharati Prakashan, 2005.
2. D. Adinarayana, and K. Syamasundar. A new sesquiterpene alcohol from Pterocarpus marsupium. Phytochemistry 21(5):1083-1085 (1982).
3. R. Maurya, R. B. Ray, F. K. Duah, D. J. Slatkin, and P. L. Schiff Jr. Constituents of Pterocarpus marsupium. J. Nat. Prod. 47:179-181 (1984).
4. J. Bruneton. Pharmacognosy Phytochemistry Medicinal Plants. France, Lavoisier Publication, 1999.
5. P. Morazzoni, and E. Bombardelli. Anti-inflammatory activity of some Gingko biloba constituents and of their phospholipids-complexes. Fitoterapia LXVII(3):263 (1996).
6. E. Bombardelli, and M. J. Magistretti, inventors. Pharmaceutical Compositions containing flavanolignans and phospholipids as active principles. EP0209037, Jan 21, 1987.
7. K. A. Connors. A Text book of Pharmaceutical Analysis. Singapore: A Wiley-Interscience Publication John Wiley and Sons, 1999.
8. J Novakonic, K Nesmerak, and H Nova. An HPTLC method for the determination and the purity control of ciprofloxacin HCL in coated tablets. J Pharm Bio Ana. 2001;957-964.
9. P. Krishna, and S. Sarasija. Standard curve of stilbene. Indian Drugs 34(2):227-228 (1997).
10. S. P. Vyas, and R. K. Khar. Targeted and Control Drug Delivery, New Delhi, India, CBS Publishers & Distributors, 2002.
11. M. Manconi, C. Sinico, D. Valenti, G. Loy, and A. M. Fadda. Niosomes as carriers for tretinoin. I.Preparation and properties. Int. J. Pharm. 234:237-248 (2002).
12. F. Kvasnicka, B. Biba, R. Sevcik, M. Voldrich, and J. Kratka. Analysis of the active compounds of silymarin. J. Chromatography A. 990:239-245 (2003).
13. A. Maitra, T. Banerjee, S. Mitra, A. K. Singh, and R. K. Sharma. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int. J. Pharm. 243:93-105 (2002).
14. M. A. Schubert, M. Harms, and C. C. Mueller-Goymann. Structural investigation on lipid nanoparticles containing high amounts of lecithin. European J. Pharm. Sci. 27:226-236 (2006).
15. R. G. Rengel, K. Barisic, Z. Pavelic, T. Z. Grubisic, I. Cepelak, and J. F. Gricic. High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. European J. Pharm. Sci. 15:441-448 (2002).
16. X. Yanyu, S. Yunmei, C. Zhipeng, and P. Oineng. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm. 307:77-82 (2006).
17. B. Jayakar, and B. Suresh. Antihyperglycaemic and hypoglycaemic activity of Aporosa lindleyana in normal and alloxan induced diabetic rats. J. Ethnopharmcol. 84:247-249 (2003).
18. M. Manickam, M. Ramanatham, M. A. Jahromi, J. P. N. Chonsouria, and A. B. Ray. Antihypoglycaemic activity of phenolics from Pterocarpus marsupium. J. Nat. Prod. 60:609-610 (1997).
19. F. Ahmad, P. Khalid, M. Chaubey, A. K. Rastogi, and J. R. Kidwai. Hypoglycaemic activity of Pterocarpus marsupium wood. J. Ethnopharmacol. 35:71-75 (1991).
20. J. A. Abdel, I. A. Abdel, and M. H. H. Al-Hakiem. Hypoglycaemic and antihyperglycemic effects of Trigonella foenum-graecum leaf in normal and allaxon induced diabetic rats. J. Ethnopharmacol. 58:149-155 (1997).
21. R. Maurya, S. S. Handa, and R. Singh. 8-(C-beta-D -glucopyranosyl)-7,3′,4′-trihydroxyflavone, process of isolation thereof, pharmaceutical composition and method for the treatment of diabetes. US Patent 6777392. August 17, 2004.
22. A. D. Skoog, J. F. Holler, and A. T. Nieman. Principle of instrumental analysis. USA, Saunders college publishing, 1997.
23. R. Maurya, and R. B. Ray. Marsupsin, A new Benzofuranone from Pterocarpus marsupium Roxb. Heterocycles 19(11):2103-2106 (1982).
24. J. Mathew, and A. V. SubbaRao. Marsupol: A novel isoflavonoid glycol from Pterocarpus marsupium. Phytochemistry 21(7):1837-1838 (1982).
25. Indena Company. Phytosome a technical revolution in phytomedicine Website Available at: http://www.indena.com/pdf/ephytosome.pdf. Accessed January 7, 2006.
26. B. Gabetta, G. Pifferi, and E. Bombardelli. Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions. US Patent 4764508. August 16, 1988.
27. â website available at: http://www.silbinol.com/ precStudies.htm accessed may 20, 2007.
28. M. Manickam, M. Ramanatham, M. A. Jahromi, J. P. N. Chonsouria, and A. B. Ray. Antihyperglycaemic activity of phenolics from Pterocarpus marsupium. J. Nat. Prod. 60: 609-610 (1997).